Authors: Keating, MJ Smith, TL Lerner, S O'Brien, S Robertson, LE Kantarjian, H Freireich, EJ

Citation: Mj. Keating et al., Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia, LEUK LYMPH, 37(1-2), 2000, pp. 71-85

Authors: Reddy, KS Wang, S Montgomery, P Grove, W Robertson, LE

Citation: Ks. Reddy et al., Fluorescence in situ hybridization identifies inversion 16 masked by t(10;16)(q24;q22), t(7;16)(q21;q22), and t(2;16)(q37;q22) in three cases of AML-M4Eo, CANC GENET, 116(2), 2000, pp. 148-152

Authors: Giles, FJ O'Brien, SM Santini, V Gandhi, V Plunkett, W Seymour, JF Robertson, LE Kantarjian, HM Keating, MJ

Citation: Fj. Giles et al., Sequential cis-platinum and fludarabine with or without arabinosyl cytosine in patients failing prior fludarabine therapy for chronic lymphocytic leukemia: A phase II study, LEUK LYMPH, 36(1-2), 1999, pp. 57-65